Delivery Order SPE2DB25D3002-SPE2DB25FLPMF

Award Date 11/13/24
Potential Completion Date 11/14/24
Potential Value $1.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,181.76 firm fixed-price contract is for the delivery of LIDOCAINE 5% PATCH 30S, a medical product, with a performance period through May 30, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC)...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of LIDOCAINE 5% PATCH 30S. The contract has an award value of $1,500.80 and a completion date of March 27, 2025. It is a Firm Fixed Price Delivery Order contract, without any set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor in the United States. The $4,006.77 firm-fixed-price delivery order is for the supply of LIDOCAINE 5% PATCH 30S, a medical product used to treat pain. The contract has an ultimate completion date of September 11, 2024. Amerisourcebergen has been awarded this contract as a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is a delivery order valued at $8,413.29, awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of LIDOCAINE 5% PATCH 30S, a medical product, with a completion date of June 7, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,077.42 firm fixed-price delivery order is for the supply of 4564754236 - LIDOCAINE 5% PATCH 30S, with a final completion date of May 31, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,510.36 Firm Fixed Price Delivery Order contract is for the supply of 4567997510 - LIDOCAINE 5% PATCH 30S, with a performance period ending on April 23, 2025. This contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with...
This federal contract award, valued at $15,061.09, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a pharmaceutical distribution and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of November 7, 2023. The contract covers the provision of LIDOCAINE 5% PATCH 30S, a medical product, to support military healthcare programs. Amerisourcebergen holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,125.90 firm-fixed-price delivery order is for the supply of LIDOCAINE 5% PATCH 30S, a specialty pharmaceutical product. The contract has an ultimate completion date of July 5, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,344.44 firm-fixed-price delivery order is for LIDOCAINE 5% PATCH 30S and has a completion date of June 26, 2025. The contract is not set-aside and is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of LIDOCAINE 5% PATCH 30S. The contract, valued at $1,181.76, is a Firm Fixed Price Delivery Order with a completion date of December 17, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
  • SPE2DB25D3002
    Indefinite Delivery Contract
  • SPE2DB25D3002-SPE2DB25FLPMF
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,456.11, is a Firm Fixed Price Delivery Order for the supply of LIDOCAINE 5% PATCH 30S. The contract has an ultimate completion date of November 14, 2024.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains.

The contract award does not have a set-aside designation, indicating open competition. Amerisourcebergen is the prime contractor, and there is no information provided about any major subcontractors.

Generated 5/20/25, 2:30 PM